MDGL
Price
$534.49
Change
+$1.37 (+0.26%)
Updated
Sep 11 closing price
Capitalization
12.34B
47 days until earnings call
Intraday BUY SELL Signals
MTNB
Price
$0.18
Change
-$0.01 (-5.00%)
Updated
Sep 11 closing price
Capitalization
2.72M
Intraday BUY SELL Signals
Interact to see
Advertisement

MDGL vs MTNB

MDGL vs MTNB Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
MDGL vs. MTNB commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDGL is a StrongBuy and MTNB is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDGL($12.3B) has a higher market cap than MTNB($2.72M). MDGL YTD gains are higher at: -8.217 vs. MTNB (-68.430). MTNB has higher annual earnings (EBITDA): -6.24M vs. MDGL (-292.07M). MDGL has more cash in the bank: 839M vs. MTNB (761K). MTNB has less debt than MDGL: MTNB (6K) vs MDGL (348M). MDGL has higher revenues than MTNB: MDGL (1.28B) vs MTNB (0).
MDGLMTNBMDGL / MTNB
Capitalization12.3B2.72M452,539%
EBITDA-292.07M-6.24M4,680%
Gain YTD-8.217-68.43012%
P/E RatioN/AN/A-
Revenue1.28B0-
Total Cash839M761K110,250%
Total Debt348M6K5,800,000%
FUNDAMENTALS RATINGS
MDGL vs MTNB: Fundamental Ratings
MDGL
MTNB
OUTLOOK RATING
1..100
7513
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
22
Undervalued
PROFIT vs RISK RATING
1..100
16100
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
4494
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MTNB's Valuation (22) in the Biotechnology industry is somewhat better than the same rating for MDGL (65) in the Pharmaceuticals Other industry. This means that MTNB’s stock grew somewhat faster than MDGL’s over the last 12 months.

MDGL's Profit vs Risk Rating (16) in the Pharmaceuticals Other industry is significantly better than the same rating for MTNB (100) in the Biotechnology industry. This means that MDGL’s stock grew significantly faster than MTNB’s over the last 12 months.

MDGL's SMR Rating (98) in the Pharmaceuticals Other industry is in the same range as MTNB (99) in the Biotechnology industry. This means that MDGL’s stock grew similarly to MTNB’s over the last 12 months.

MDGL's Price Growth Rating (44) in the Pharmaceuticals Other industry is somewhat better than the same rating for MTNB (94) in the Biotechnology industry. This means that MDGL’s stock grew somewhat faster than MTNB’s over the last 12 months.

MDGL's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as MTNB (100) in the Biotechnology industry. This means that MDGL’s stock grew similarly to MTNB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MDGLMTNB
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 17 days ago
77%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 5 days ago
80%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (MDGL: $534.49 vs. MTNB: $0.19)
Brand notoriety: MDGL and MTNB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MDGL: 58% vs. MTNB: 10%
Market capitalization -- MDGL: $12.34B vs. MTNB: $2.72M
MDGL [@Biotechnology] is valued at $12.34B. MTNB’s [@Biotechnology] market capitalization is $2.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MDGL’s FA Score shows that 1 FA rating(s) are green while MTNB’s FA Score has 1 green FA rating(s).

  • MDGL’s FA Score: 1 green, 4 red.
  • MTNB’s FA Score: 1 green, 4 red.
According to our system of comparison, MDGL is a better buy in the long-term than MTNB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MDGL’s TA Score shows that 5 TA indicator(s) are bullish while MTNB’s TA Score has 4 bullish TA indicator(s).

  • MDGL’s TA Score: 5 bullish, 3 bearish.
  • MTNB’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, MDGL is a better buy in the short-term than MTNB.

Price Growth

MDGL (@Biotechnology) experienced а -1.22% price change this week, while MTNB (@Biotechnology) price change was +1.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

MDGL is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
MDGL
Daily Signal:
Gain/Loss:
MTNB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHSN1.050.01
+0.96%
Chanson International Holding
AGI35.920.25
+0.70%
Alamos Gold
HYPR0.79N/A
+0.47%
Hyperfine
NOAH8.14-0.03
-0.37%
Noah Holdings Limited
BVC16.05-0.20
-1.23%
BitVentures Limited

MTNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTNB has been loosely correlated with HIND. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MTNB jumps, then HIND could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTNB
1D Price
Change %
MTNB100%
-9.76%
HIND - MTNB
41%
Loosely correlated
-1.90%
SPRC - MTNB
35%
Loosely correlated
+2.01%
AXON - MTNB
34%
Loosely correlated
+0.10%
VKTX - MTNB
32%
Poorly correlated
-0.47%
MDGL - MTNB
31%
Poorly correlated
+0.26%
More